AS
Therapeutic Areas
Jubilant Pharmova Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Oncology Injectables Portfolio | Various Cancers | ANDA Filed/Approved |
| Radiopharmaceuticals (Theragnostics) | Prostate Cancer, Neuroendocrine Tumors | Clinical/Commercial |
| REMOXY (oxycodone) ER | Chronic Pain | NDA Resubmitted |
| Complex Generic APIs | CNS, Cardiovascular, Metabolic | Development |
| Allergy Immunotherapy (SLIT) | Ragweed/Grass Pollen Allergy | Marketed/Development |
| Biosimilars Pipeline | Immunology, Oncology | Early Development |
Leadership Team at Jubilant Pharmova
SS
Shyam S Bhartia
Chairman and Co-Founder
HS
Hari S Bhartia
Co-Chairman and Co-Founder
PY
Pramod Yadav
Chief Executive Officer
RS
Rahul S. Bhartia
Member of the Board
AK
Ashish K. Bhargava
Chief Financial Officer
DS
Dr. Shyam B. Ghodawat
President, Global Quality & Operations